Pathogenetic mechanisms in dengue haemorrhagic fever: report of an international collaborative study.
In a study of 55 persons with dengue haemorrhagic fever-36 of whom showed the dengue shock syndrome-clinical, haematological, virological, and serological changes were correlated with serial measurements of complement components and immunopathological studies. Viruses dengue-1 or dengue-2 were isolated from the sera of 9 patients. Serological responses indicative of secondary dengue virus infections were observed in 53 patients; 2 (infants) had primary infections. During the acute phase of the disease, dengue antibody titres rose logarithmically. Marked depression of complement components, especially C3, was observed. Activation of both the classical and alternative complement pathways was demonstrated, with depression of both C4 and C3 proactivator levels in most instances, although in some cases it appeared that one mechanism was involved to a greater extent than the other. The level of depression of C3 was correlated with the severity of the disease. Relatively stable transferrin levels indicated that depletion of complement proteins was not primarily due to extravasation. Fibrinogen levels were depressed and fibrinogen split products were found in the plasma. The accumulated data provide further evidence of the central role that activated complement components play in the pathogenesis of dengue haemorrhagic fever.
D001780:Blood Coagulation Tests; D002648:Child; D003165:Complement System Proteins; D003715:Dengue / Q000276:immunology / Q000382:microbiology / Q000503:physiopathology*; D003716:Dengue Virus / Q000302:isolation & purification; D005260:Female; D005340:Fibrinogen; D005455:Fluorescent Antibody Technique; D006385:Hemagglutination Inhibition Tests; D006482:Hemorrhagic Fevers, Viral / Q000276:immunology / Q000503:physiopathology*; D006801:Humans; D007223:Infant; D007391:International Cooperation; D008297:Male; D013785:Thailand; D014168:Transferrin / Q000097:blood; D010948:Viral Plaque Assay; D014944:World Health Organization
D014168:Transferrin; D005340:Fibrinogen; D003165:Complement System Proteins